About QPS Bioserve:

QPS Bioserve Vision:

Bioserve was established in 2005 with the vision of   providing quality clinical   research services to sponsors that enable  them to validate their innovative products by:

• Providing services that exceed the sponsor requirements of quality, compliance, time and cost
• Committed compliance to regulatory and ethical standards
• Ensuring the safety, dignity and well-being of all study participants

About QPS:
QPS provides GLP/GCP-compliant preclinical and clinical research services to pharmaceutical and biotechnology clients worldwide in the areas of Bioanalysis, Drug Metabolism and Pharmacokinetics, Translational Medicine, and Clinical Research. Founded by Dr. Ben Chien in 1995, QPS has Bioanalysis and Preclinical testing facilities at its Newark, DE headquarters; in Groningen, the Netherlands; and in Taipei, Taiwan. Early-phase clinical facilities are located in Springfield, MO; Taipei, Taiwan; and Groningen, the Netherlands. Business development offices are maintained in the US, Europe, and Asia.www.qps-usa.com

Bioserve Promoters:
In early 2011, QPS LLC has acquired a majority stake in Bioserve. Bioserve is promoted by the founders of Vijaya Diagnostic Centre, one of the pioneers in diagnostic Medicare for the last 30 years

Vijaya Diagnostic Centre is a ISO 9001:2000 Certified and NABL-ISO 15189 Accredited Medical Laboratory offering a comprehensive range of diagnostic services

Promoters bring a wealth of experience in the healthcare and clinical domain combined with a passion for quality

Mr. Suneil S Reddy is the Managing Director heading Bioserve having over 12 years of experience in the healthcare business and is a successful entrepreneur

Team
Team QPS Bioserve includes qualified and experienced professionals from the pharmaceutical domain with understanding of the regulatory and sponsor requirements. The team is committed to science and meeting the challenges of research by providing seamless outsourcing solutions with professionalism, flexibility and reliability. They are supported by a team of about 100 committed professionals.

Inspections

• WHO inspected in May 2010.
• UK MHRA inspected in March 2010.
• USFDA inspected in March 2008 and July 2009.